Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
12.90
-0.08 (-0.62%)
Aug 4, 2026, 3:00 PM CST

SHA:688526 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
389.72418.72382.35395.93409.52570.74
Depreciation & Amortization
113.25113.25109.5114.2797.6962.64
Other Amortization
0.480.480.330.23--
Loss (Gain) From Sale of Assets
6.96.90.330.09--
Asset Writedown & Restructuring Costs
0.860.863.311.72-1.291.57
Loss (Gain) From Sale of Investments
-40.68-40.68-37.6-9.34-6.65-5.13
Provision & Write-off of Bad Debts
-10.17-10.1711.8884.4723.497.85
Other Operating Activities
-94.09-33.53-33.46-36.09-41.45-52.19
Change in Accounts Receivable
54.5554.55-20.4-19.85-134.36-118.72
Change in Inventory
-30.95-30.956.438.81-67.96-38.5
Change in Accounts Payable
-16.27-16.27-34.0715.15121.3677.77
Change in Other Net Operating Assets
4.834.83--6.749.07
Operating Cash Flow
378.98468.54392.68538.03423.71531.27
Operating Cash Flow Growth
-5.17%19.32%-27.02%26.98%-20.25%32.77%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-119.24-123.88-106.94-104.5-102.85-374.45
Sale of Property, Plant & Equipment
7.757.752.590.180.08-
Cash Acquisitions
-4.5-4.5--4.05-8.46-
Investment in Securities
-646.88-686.24161.16-281.45-582.1412
Other Investing Activities
168.34157.9739.7860.8356.2431.35
Investing Cash Flow
-594.53-648.8996.59-329-637.13-331.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--97236.5271.578
Total Debt Issued
--97236.5271.578
Long-Term Debt Repaid
--1.4-385.09-222.84-78.84-60.01
Net Debt Issued (Repaid)
-1.4-1.4-288.0913.66192.6617.99
Issuance of Common Stock
17.6917.69--14.841.86
Repurchase of Common Stock
-1.08-1.08-35.29---
Common Dividends Paid
-199.48-199.48-204.58-97.09-93.48-136.82
Other Financing Activities
0.53-24.79-19-0.5-4.22
Financing Cash Flow
-183.74-184.27-503.18-102.43113.52-121.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.06-2.060.020.05--
Net Cash Flow
-401.36-366.68-13.89106.67-99.8978.99

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
259.74344.66285.74433.53320.86156.82
Free Cash Flow Growth
-8.91%20.62%-34.09%35.12%104.60%-45.65%
Free Cash Flow Margin
27.87%36.29%30.34%40.74%32.05%14.22%
Free Cash Flow Per Share
0.560.740.610.930.690.34
Levered Free Cash Flow
876.66216.86435.7238.93134.02-1.1
Unlevered Free Cash Flow
876.66216.86438.744.03137.430.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
111.8591.77109.8598.396.7586.87
Change in Working Capital
12.712.7-43.96-13.26-57.58-54.22